Live News Categoriesequity

Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ) News

Track canonical SquawkNews coverage tagged to 300485.SZ, Beijing Science Sun Pharmaceutical Co., Ltd.. This hub brings together deduplicated headlines about shenzhen, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol 300485.SZ Asset equity Sector Markets 90 days 1 Last 8.47 Updated Sep 29, 2026, 06:04 AM UTC Open live news feed

M Sun Pharma deal for lerodalcibep worldwide (ex US, China) seen lifting revenue potential Axis and DAM Capital say Sun Pharma’s exclusive licensing with LIB Therapeutics for lerodalcibep could generate over $700m in peak sales; shares rose up to 1.32% and analysts rate it a buy with median target 2,150 rupees EQUITY | Sep 29, 2026, 06:04 AM UTC